Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,511 GBX | +0.03% |
|
-1.21% | +4.19% |
05:31pm | GSK: FIRST SINGLE-DOSE MEDICINE TO PREVENT RELAPSE OF P. VIVAX M… | RE |
02:19pm | GSK launches antimalarial drug in Thailand and Brazil | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.19% | 7.86TCr | |
+56.91% | 81TCr | |
+39.52% | 62TCr | |
-6.89% | 35TCr | |
+7.52% | 29TCr | |
+13.74% | 24TCr | |
+13.83% | 22TCr | |
-0.49% | 22TCr | |
+7.82% | 17TCr | |
-2.73% | 16TCr |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GSK Signs New Licensing Deal With CureVac for Influenza, Covid-19 Vaccines